Chemoradiotherapy, Adjuvant
"Chemoradiotherapy, Adjuvant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Combined chemotherapy and radiotherapy given to augment some other form of treatment such as surgery. It is commonly used in the therapy of cancer.
| Descriptor ID |
D059186
|
| MeSH Number(s) |
E02.186.079.500 E02.319.164.500 E02.815.160.500
|
| Concept/Terms |
Chemoradiotherapy, Adjuvant- Chemoradiotherapy, Adjuvant
- Adjuvant Chemoradiotherapies
- Chemoradiotherapies, Adjuvant
- Adjuvant Radiochemotherapy
- Adjuvant Radiochemotherapies
- Radiochemotherapies, Adjuvant
- Radiochemotherapy, Adjuvant
- Adjuvant Chemoradiotherapy
|
Below are MeSH descriptors whose meaning is more general than "Chemoradiotherapy, Adjuvant".
Below are MeSH descriptors whose meaning is more specific than "Chemoradiotherapy, Adjuvant".
This graph shows the total number of publications written about "Chemoradiotherapy, Adjuvant" by people in this website by year, and whether "Chemoradiotherapy, Adjuvant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 4 | 5 |
| 2014 | 0 | 2 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 3 | 3 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemoradiotherapy, Adjuvant" by people in Profiles.
-
Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809. Ann Surg Oncol. 2024 Aug; 31(8):4837-4838.
-
Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2024 Jun; 167(6):1943-1950.
-
R1 pancreatic cancer patients benefit from chemoradiation when initiation of adjuvant therapy is delayed. Surg Oncol. 2023 Aug; 49:101961.
-
Adjuvant Therapies for Esophageal Cancer. Thorac Surg Clin. 2022 Nov; 32(4):457-465.
-
The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis. Ann Surg. 2021 12 01; 274(6):e564-e573.
-
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). J Clin Oncol. 2022 01 10; 40(2):138-149.
-
Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma. Br J Surg. 2021 10 23; 108(10):1207-1215.
-
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1?+ tucatinib/placebo in patients with residual HER2-positive invasive breast cancer. Future Oncol. 2021 Dec; 17(34):4665-4676.
-
Adjuvant nivolumab after preoperative chemoradiotherapy and surgery in esophageal cancer: A shifting paradigm. J Thorac Cardiovasc Surg. 2022 08; 164(2):433-437.
-
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-na?ve prostate cancer. Eur J Cancer. 2021 11; 157:259-267.